Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Vector1 who wrote (5176)	12/19/2001 1:18:31 PM
From: Biomaven	Read Replies (1) \| Respond to of 52153

V1 & Michael, I agree that they may well still be negotiating here, but the lack of an immediate partner announcement does hurt. I sold my call options and part of my holding on the announcement, but still have kept a reasonable sized position. As V1 pointed out, they had a deadline with the approval announcement, and big pharma don't move quickly, particularly during the huge crush of office parties near year-end. <g> Niaspan sales have been very strong. According to a post on Yahoo: New: 20,526 Total: 51,922 which I believe are all-time highs. I'm not displeased that BMY didn't bite - there would always have been the worry that they weren't wholly behind the product. I suspect that they will ultimately end up with some sort of partnering arrangement here, perhaps along the same lines that SEPR/ABT did with Xopenex. Peter

To: Vector1 who wrote (5176)	12/19/2001 10:34:16 PM
From: Michael Young	Read Replies (1) \| Respond to of 52153

I've been in KOSP for several years. Management consistently stated they were seeking a good partner. They have had plenty of time since BMY announced the deal with DD, yet they haven't found a good partner willing to offer reasonable terms. It tells me that the sales potential isn't as high as many of us expected. This is a tremendous disappointment. I sold out at at the open yesterday. I might consider a short position on any rally. I think the stock has significant downside in the near term. MIKE